Characteristics of Sexual Dysfunction in Patients With Lung Cancer
LUDICAS
LUDICAS
Sponsor study identifier
observational
553
5 countries
29
Study Start
July 13, 2023
Actual (reported)Primary Completion
February 29, 2024
Actual (reported)Study Completion
February 29, 2024
Actual (reported)The general objective of this observational study is identify and describe the type, frequency, and severity of sexual dysfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population. The recruitment will be carried out from July 2023 and will be carried out until December 2023, the analysis of the information will be carried out from January to March 2024.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 29, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 13, 2023
Actual (reported)August 25, 2023
Actual (reported)August 30, 2023
Actual (reported)February 29, 2024
Actual (reported)February 29, 2024
Actual (reported)February 6, 2026
Actual (reported)Number of Participants With Different Type, Frequency and Severity of Sexual Dysfunction
Identify and describe the type, frequency, and severity of sexual disfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population.
From inclusion up to 3 months
* Age greater than or equal to 18 years and less than or equal to 70 years. * Diagnosis of lung cancer stages IB to IV. * Having received systemic oncological treatment for at least 3 months * ECOG ≤ 2
Oncological systemic treatment for at least 3 months or being in oncological follow-up after having received systemic treatment for a minimum of 3 months
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with lung cancer stages IB to IV with ECOG ≤ 2 between 18 and 70 years old that received systemic oncological treatment for at least 3 months.
Instituto Alexander Flemming
Buenos Aires, Buenos Aires, Argentina
Clínica Universitaria Colombia
Bogotá, Bogota D.C., Colombia
Clinica del Occidente
Cali, Cali, Colombia
Hematooncologos SA
Cali, Cali, Colombia
Clínica de Medellín
Medellín, MEdellín, Colombia
Oncomedica, IMAT
Montería, Monteria, Colombia
ALIADAS Instituto Nacional de Enfermedades Neoplasicas
Surquillo, Perú, 15038, Peru
Ospina-Serrano AV, Maximiano C, Cantos B, Torrente M, Mendez M, Sanchez JC, Calvo V, Collazo-Lorduy A, Blanco M, Nunez B, Triana I, Parejo C, Martinez P, Duma N, Provencio-Pulla M. Sexual dysfunction in patients with cancer, a challenge in oncology practice: results of the CLARIFY project. Clin Transl Oncol. 2024 May;26(5):1147-1156. doi: 10.1007/s12094-023-03332-0. Epub 2023 Nov 2.
Aylen Vanessa Ospina Serrano, MD
Hospital Puerta del Hierro Investigator
553 participants (actual enrollment reported by the registry).
First Submitted
August 25, 2023
First Posted
August 30, 2023
Study Start
July 13, 2023
Actual (reported)MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
Contact the study team to confirm eligibility.
Centro Hospitalar do Porto
Porto, Porto District, 4099-001, Portugal
Hospital General de Elche
Elche, Alicante, 03203, Spain
ICO Badalona, Hospital Germans Trias i Pujol
Badalona, Barcelona, 08916, Spain
Hospital Universitari Vall d' Hebron
Barcelona, Barcelona, 08035, Spain
Hospital General de Granollers
Granollers, Barcelona, 08402, Spain
Hospital La Mancha Centro
Alcázar de San Juan, Ciudad Real, 13600, Spain
Hospital General Universitario de Ciudad Real
Ciudad Real, Ciudad Real, 13005, Spain
Hospitalario Universitario A Coruña
A Coruña, La Coruña, 15006, Spain
Hospital Universitario Lucus Augusti
Lugo, Lugo, 27003, Spain
Hospital de Fuenlabrada
Fuenlabrada, Madrid, 28942, Spain
Hospital Clínico San Carlos
Madrid, Madrid, 28040, Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, Madrid, 28040, Spain
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, 28222, Spain
Hospital Infanta Sofia
San Sebastián de los Reyes, Madrid, 28702, Spain
Hospital Universitari Son Llatzer
Palma de Mallorca, Palma de Mallorca, 07198, Spain
Hospital Clínico de Salamanca
Salamanca, Salamanca, 37007, Spain
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Santa Cruz de Tenerife, 38010, Spain
Xarxa sanitaria Santa Tecla- Tarragona
Tarragona, Tarragona, 43003, Spain
Hospital General Universitario de Valencia
Valencia, Valencia, 46014, Spain
Hospital Universitario La Fe
Valencia, Valencia, 46026, Spain
Hospital Clínico Universitario de Valladolid
Valladolid, Valladolid, 47003, Spain
Hospital Universitario Cruces
Barakaldo, Vizcaya, 48903, Spain
Primary Completion
February 29, 2024
Actual (reported)Study Completion
February 29, 2024
Actual (reported)Last Updated
February 6, 2026
Results First Posted
February 6, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: